Ana Zarubica

Title: Ana Zarubica: Innovator in Medicinal Chemistry

Introduction

Ana Zarubica is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic agents. Her work focuses on addressing diseases related to cell adhesion molecules, which are crucial in various medical conditions.

Latest Patents

Ana Zarubica holds a patent for "Antagonists of GRASP55 for use as a medicament." This invention concerns antagonists of the Golgi reassembly-stacking protein of 55 kDa (Grasp55), which are intended for use in treating diseases associated with cell adhesion molecules, notably those involving MCAM or JAMs. The patent outlines potential applications in the treatment of cancer, metastases, and inflammatory diseases. Additionally, it provides methods for screening compounds that may treat or prevent such diseases.

Career Highlights

Throughout her career, Ana Zarubica has worked with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale and the Université de la Méditerranée Aix-Marseille II. Her research has significantly advanced the understanding of cell adhesion and its implications in various diseases.

Collaborations

Ana has collaborated with notable professionals in her field, including Michel Aurrand-Lions. Their joint efforts have contributed to the development of innovative solutions in medicinal chemistry.

Conclusion

Ana Zarubica's work exemplifies the impact of innovative research in the medical field. Her contributions to the understanding and treatment of diseases related to cell adhesion molecules highlight the importance of continued exploration in medicinal chemistry.